- Home
- ZIMV vs ANIK Comparison
ZIMV vs ANIK Comparison
Compare ZIMV & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIMV
- ANIK
- Stock Information
- Founded
- ZIMV 2021
- ANIK 1983
- Country
- ZIMV United States
- ANIK United States
- Employees
- ZIMV N/A
- ANIK N/A
- Industry
- ZIMV Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ANIK Medical/Dental Instruments
- Sector
- ZIMV Health Care
- ANIK Health Care
- Exchange
- ZIMV Nasdaq
- ANIK Nasdaq
- Market Cap
- ZIMV 434.5M
- ANIK 364.2M
- IPO Year
- ZIMV N/A
- ANIK 1993
- Fundamental
- Price
- ZIMV $13.74
- ANIK $17.43
- Analyst Decision
- ZIMV Hold
- ANIK Buy
- Analyst Count
- ZIMV 3
- ANIK 2
- Target Price
- ZIMV $18.33
- ANIK $24.50
- AVG Volume (30 Days)
- ZIMV 162.0K
- ANIK 151.8K
- Earning Date
- ZIMV 10-30-2024
- ANIK 10-31-2024
- Dividend Yield
- ZIMV N/A
- ANIK N/A
- EPS Growth
- ZIMV N/A
- ANIK N/A
- EPS
- ZIMV N/A
- ANIK N/A
- Revenue
- ZIMV $451,294,000.00
- ANIK $164,168,000.00
- Revenue This Year
- ZIMV $0.83
- ANIK N/A
- Revenue Next Year
- ZIMV $1.27
- ANIK N/A
- P/E Ratio
- ZIMV N/A
- ANIK N/A
- Revenue Growth
- ZIMV 267.15
- ANIK 0.52
- 52 Week Low
- ZIMV $9.00
- ANIK $16.00
- 52 Week High
- ZIMV $22.40
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- ZIMV 41.74
- ANIK 31.24
- Support Level
- ZIMV $13.01
- ANIK $16.70
- Resistance Level
- ZIMV $14.76
- ANIK $17.35
- Average True Range (ATR)
- ZIMV 0.48
- ANIK 0.73
- MACD
- ZIMV 0.01
- ANIK 0.17
- Stochastic Oscillator
- ZIMV 28.85
- ANIK 76.00
About ZIMV ZimVie Inc.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.